CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.290
+0.110 (9.32%)
At close: Jun 5, 2026, 4:00 PM EDT
1.200
-0.090 (-6.98%)
After-hours: Jun 5, 2026, 6:19 PM EDT
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $15.26 million as of June 5, 2026. Its market cap has decreased by -37.01% in one year.
Market Cap
15.26M
Enterprise Value
14.01M
1-Year Change
-37.01%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $15.26M, a decrease of -66.90%. That is a compound annual growth rate of -29.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 15.26M | -0.92% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CalciMedica | 16.69M |
| Quince Therapeutics | 16.46M |
| Lipocine | 16.45M |
| Lexaria Bioscience | 15.79M |
| NewcelX | 15.77M |
| GT Biopharma | 15.74M |
| Moolec Science | 15.54M |
| Citius Pharmaceuticals | 15.37M |